RNA Outsourcing Videos

1. Cell & Gene Therapies – Changing The Healthcare Landscape 7/20/2023

   Experts discuss how cell & gene therapies are changing the healthcare landscape and what needs to be done to bring these advanced therapies to patients.

2. The Synergistic Role Of Drug Safety In Clinical Trial Operations 4/25/2024

   Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.

3. mRNA’s Impact On Cost And Capacity To Surge Biopharma Production 5/22/2023

   TFF Pharmaceuticals’ Kayla Hannon and University of Sheffield’s Dr. Zoltán Kis discuss the cost and capacity implications of therapeutic demand surges in this Surge Manufacturing for Biopharma Resilience segment.

4. Gain Support For Your Regulatory Submission Process 3/27/2024

   Join us in this video as we delve into invaluable tips, cutting-edge tools, and unwavering support that Cytiva offers to facilitate your documentation progress.

5. How A Sponsored CMC Platform Accelerates mRNA Projects Into The Clinic 1/31/2023

   Developing a client-sponsored Target Product Profile (TPP) and Analytical Target Profile (ATP) is critical to move your drug product to clinic efficiently and meet acceptance criteria.

6. A Deeper Dive On Mitigating Financial Risk Before Selecting A Vendor 1/23/2024

   In part two of this webinar series, presenters focus on avoiding potential risks such as unexpected budget changes and unplanned change orders that could jeopardize the success of a clinical trial.

7. Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development 6/12/2023

   To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.

8. Plasmid DNA And Advanced Therapies: Accelerating Path To Clinic

   Examine the challenges CGT innovators face and how adhering to GMP requirements from an early stage helps to ensure successful downstream applications from early clinical development to commercial phase.

9. Validation Of mRNA Concentration Determination 8/20/2023

   mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.

10. mRNA Manufacturing: In House Or Outsourced? 3/31/2022

    Speaking of outsourcing, Akhilesh Bhambhani, Sr. Director, Biologics Drug Product Development at Ultragenyx Pharmaceuticals and Roberta Duncan, VP and mRNA Program Lead at Seqirus share what they’re manufacturing in house, what they’re outsourcing, and why in this segment from our recent CMC, Scale Up, & The Road To mRNA Regulatory Approval event.